Ozempic is self-administered via a pre-filled pen, and the injection can be given in the abdomen, thigh, or upper arm
A 75-year-old man with type 2 diabetes was switched from 14 mg daily of oral semaglutide (Rybelsus) to subcutaneous tirzepatide
51.2% (M) when the mother had HAE-C1-INH and 43.3% (F) vs
Notch signaling in pancreatic endocrine cell and diabetes
[DOI] [PubMed] [Google Scholar] 85.Hengst L, Reed SI

Use this icon in BioRender along with 1000s of others to make your next science figure in minutes SIGN UP FREE Keywords injector,auto injector,auto-injector,autoinjector,injector device,injector pen,inject,semaglutide,diabetes,anti-diabetes,anti-diabetic,type 2 diabetes,Ozempic,Rybelsus,Wegovy,glycemic control,obesity,anti-obesity,weight management,weight loss,auto syringe,self-injectable,injectable,medication pen,medication,injection,pen,capped,needle,metabolic,syndrome,treatment,treat,therapy,tip,medicine,plunger,dose window,selection,dial,dose,disposable,button,at-home,one-use,spring-loaded syringes,syringe,actuator,self-administration,drug delivery,prefilled syringe,intramuscular,subcutaneous,single use,portable injector,medical device,medical equipment,medical instrument,medical apparatus,medical tool,medical appliance,content-refinement-GLP-1-expansion,Rybelsus,Wegovy,semaglutide Autoinjector (semaglutide) icon JPEG Autoinjector (semaglutide) icon PNG Autoinjector (semaglutide) icon SVG Autoinjector (semaglutide) icon GIF BioRender icons and templates meet journal, grant, and copyright standards
